This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ding, W.-Q. Articles by Lind, S. E. Search for Related Content PubMed PubMed Citation Articles by Ding, W.-Q. Articles by Lind, S. E.

Anticancer Activity of the Antibiotic Clioquinol

Departments of Pathology and Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Requests for reprints: Wei-Qun Ding, University of Oklahoma Health Sciences Center, 975 Northeast 10th Street, BRC-409, Oklahoma City, OK 73104. Phone: 405-271-1605; Fax: 405-271-6289; E-mail: weiqun-ding{at}ouhsc.edu.

Clioquinol, a metal chelator, has been used for many years as an antimicrobial agent and more recently as a potential treatment for Alzheimer's disease. Because it binds copper and zinc, metals essential for the activity of the enzyme superoxide dismutase-1 (SOD1), a potential target for anticancer drug development, we investigated its effects on human cancer cells. Treatment with clioquinol reduced the viability of eight different human cancer cell lines in a concentration-dependent manner, with IC₅₀ values in the low micromolar range. Biochemical analysis revealed that clioquinol induced cancer cell death through apoptotic pathways that require caspase activity. Although clioquinol induced modest inhibition of SOD1 activity in treated cells, comparable inhibition by a known SOD1 inhibitor, diethyldithiocarbamate, did not result in cytotoxicity. The addition of copper, iron, or zinc did not rescue cells from cliquinol-induced cytotoxicity but enhanced its killing, arguing against metal chelation as its major mechanism of action. To test if clioquinol might act as an ionophore, a fluorescent probe was used to monitor intracellular zinc concentrations. The addition of clioquinol resulted in elevated levels of intracellular zinc, indicating that clioquinol acts as a zinc ionophore. In an in vivo xenografts mouse model, clioquinol inhibited tumor growth of xenografts over a 6-week period, without inducing visible toxicity. Our results show that clioquinol has anticancer effects both in vitro and in vivo. Transition metal ionophores may be a subclass of metal chelators with anticancer activity deserving of further development.

This article has been cited by other articles:

				Y. Wang, R. Branicky, Z. Stepanyan, M. Carroll, M.-P. Guimond, A. Hihi, S. Hayes, K. McBride, and S. Hekimi The Anti-neurodegeneration Drug Clioquinol Inhibits the Aging-associated Protein CLK-1 J. Biol. Chem., January 2, 2009; 284(1): 314 - 323. [Abstract] [Full Text] [PDF]

				D. Magda, P. Lecane, Z. Wang, W. Hu, P. Thiemann, X. Ma, P. K. Dranchak, X. Wang, V. Lynch, W. Wei, et al. Synthesis and Anticancer Properties of Water-Soluble Zinc Ionophores Cancer Res., July 1, 2008; 68(13): 5318 - 5325. [Abstract] [Full Text] [PDF]

				R. A. Colvin, A. I. Bush, I. Volitakis, C. P. Fontaine, D. Thomas, K. Kikuchi, and W. R. Holmes Insights into Zn2+ homeostasis in neurons from experimental and modeling studies Am J Physiol Cell Physiol, March 1, 2008; 294(3): C726 - C742. [Abstract] [Full Text] [PDF]

				T. Du, G. Filiz, A. Caragounis, P. J. Crouch, and A. R. White Clioquinol Promotes Cancer Cell Toxicity through Tumor Necrosis Factor {alpha} Release from Macrophages J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 360 - 367. [Abstract] [Full Text] [PDF]

				W.-Q. Ding and S. E. Lind Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid-induced cytotoxicity Mol. Cancer Ther., April 1, 2007; 6(4): 1467 - 1474. [Abstract] [Full Text] [PDF]

				D. Chen, Q. C. Cui, H. Yang, R. A. Barrea, F. H. Sarkar, S. Sheng, B. Yan, G. P. V. Reddy, and Q. P. Dou Clioquinol, a Therapeutic Agent for Alzheimer's Disease, Has Proteasome-Inhibitory, Androgen Receptor-Suppressing, Apoptosis-Inducing, and Antitumor Activities in Human Prostate Cancer Cells and Xenografts Cancer Res., February 15, 2007; 67(4): 1636 - 1644. [Abstract] [Full Text] [PDF]

				S. M. Choi, K.-O. Choi, Y.-K. Park, H. Cho, E. G. Yang, and H. Park Clioquinol, a Cu(II)/Zn(II) Chelator, Inhibits Both Ubiquitination and Asparagine Hydroxylation of Hypoxia-inducible Factor-1{alpha}, Leading to Expression of Vascular Endothelial Growth Factor and Erythropoietin in Normoxic Cells J. Biol. Chem., November 10, 2006; 281(45): 34056 - 34063. [Abstract] [Full Text] [PDF]

				W.-Q. Ding, B. Liu, J. L. Vaught, R. D. Palmiter, and S. E. Lind Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Mol. Cancer Ther., July 1, 2006; 5(7): 1864 - 1872. [Abstract] [Full Text] [PDF]

				A. R. White, T. Du, K. M. Laughton, I. Volitakis, R. A. Sharples, M. E. Xilinas, D. E. Hoke, R. M. D. Holsinger, G. Evin, R. A. Cherny, et al. Degradation of the Alzheimer Disease Amyloid beta-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity J. Biol. Chem., June 30, 2006; 281(26): 17670 - 17680. [Abstract] [Full Text] [PDF]